BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12661036)

  • 1. Expression of NKX3.1 in normal and malignant tissues.
    Gelmann EP; Bowen C; Bubendorf L
    Prostate; 2003 May; 55(2):111-7. PubMed ID: 12661036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.
    Bowen C; Bubendorf L; Voeller HJ; Slack R; Willi N; Sauter G; Gasser TC; Koivisto P; Lack EE; Kononen J; Kallioniemi OP; Gelmann EP
    Cancer Res; 2000 Nov; 60(21):6111-5. PubMed ID: 11085535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of NKX3.1 expression in prostate cancer tissues and correlation with clinicopathologic features.
    Aslan G; Irer B; Tuna B; Yorukoglu K; Saatcioglu F; Celebi I
    Pathol Res Pract; 2006; 202(2):93-8. PubMed ID: 16413692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The specific expression profile of homeobox gene NKX3.1 mRNA and protein in prostate tissues and its relationship with primary prostate cancer].
    Yang GS; Wang YM; Chen ZD
    Zhonghua Nan Ke Xue; 2006 Feb; 12(2):137-40, 144. PubMed ID: 16519150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of NKX3.1 in benign prostatic hyperplasia.
    Irer B; Toylu A; Aslan G; Celebi I; Yorukoglu K; Atabey N
    Urology; 2009 May; 73(5):1140-4. PubMed ID: 18597829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer.
    Asatiani E; Huang WX; Wang A; Rodriguez Ortner E; Cavalli LR; Haddad BR; Gelmann EP
    Cancer Res; 2005 Feb; 65(4):1164-73. PubMed ID: 15734999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
    Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
    Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1.
    Abdulkadir SA
    Ann N Y Acad Sci; 2005 Nov; 1059():33-40. PubMed ID: 16382041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of ALX4 expression in epithelial cells and adjacent stromal cells in breast cancer.
    Chang H; Mohabir N; Done S; Hamel PA
    J Clin Pathol; 2009 Oct; 62(10):908-14. PubMed ID: 19783719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function.
    Gelmann EP; Steadman DJ; Ma J; Ahronovitz N; Voeller HJ; Swope S; Abbaszadegan M; Brown KM; Strand K; Hayes RB; Stampfer MJ
    Cancer Res; 2002 May; 62(9):2654-9. PubMed ID: 11980664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of NKX3.1 in LNCaP prostate cancer cells by RNA interference.
    Possner M; Heuser M; Kaulfuss S; Scharf JG; Schulz W; Hermann-Ringert R; Thelen P
    Int J Oncol; 2008 Apr; 32(4):877-84. PubMed ID: 18360715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The signaling adapter protein PINCH is up-regulated in the stroma of common cancers, notably at invasive edges.
    Wang-Rodriguez J; Dreilinger AD; Alsharabi GM; Rearden A
    Cancer; 2002 Sep; 95(6):1387-95. PubMed ID: 12216108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Nkx3.1 enhances 17beta-estradiol anti-tumor action in PC3 human prostate cancer cells.
    Wang P; Liu B; Luo JD; Zhang ZG; Ma Q; Chen ZD
    Asian J Androl; 2007 May; 9(3):353-60. PubMed ID: 17486276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer.
    Bobinac D; Marić I; Zoricić S; Spanjol J; Dordević G; Mustać E; Fuckar Z
    Croat Med J; 2005 Jun; 46(3):389-96. PubMed ID: 15861517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical detection of prostate specific antigen expression in human breast carcinoma cells.
    Bodey B; Bodey B; Kaiser HE
    Anticancer Res; 1997; 17(4A):2577-81. PubMed ID: 9252683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
    Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
    Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the homeobox gene NKX3.1 by all-trans retinoic acid in prostate cancer cells.
    Thomas MA; Hodgson MC; Loermans SD; Hooper J; Endersby R; Bentel JM
    J Cell Biochem; 2006 Dec; 99(5):1409-19. PubMed ID: 16817226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.